Helping set patients at risk for sepsis on the right clinical path
Let’s collaborate to optimize how you manage patients across the sepsis care pathway using BD solutions. The approach will include:
By focusing on the sepsis care pathway—from recognition of patients at-risk for sepsis through their treatment—using BD solutions, you can start on the journey of:
With the ultimate goal of reducing time to appropriate therapy and improving patient outcomes.
Sepsis Care Approach
Mortality from septic shock increases 7.6% for every hour that treatment is delayed4 among patients with septic shock within the first 6 hours of onset of hypotension. The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment.
~ 80% of skin flora reside in the first five layers of our outermost skin.5 Proper skin preparation kills bacteria on the skin that can potentially cause skin infection and contamination.
~ 20% of blood culture samples have been reported as underfilled in the U.S.6 Support optimal blood culture specimen collection; sufficient blood volume is a critical determinant for optimal organism recovery. The yield of pathogens recovered increases in direct proportion to the volume of blood cultured. 6
80% of sepsis deaths could be prevented by quicker diagnosis and treatment.7 Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching.8
5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients. 9 Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.
The ChloraPrep™ preoperative skin preparation product line provides a formulation that has set the standard of care in infection prevention for over 18 years. Learn more about ChloraPrep™.
BD Vacutainer® UltraTouch™ push button blood collection set
With propriety BD PentaPoint™ and BD RightGauge™ needle technology, the BD Vacutainer® UltraTouch™ push button blood collection set aims to improve the patient experience by enhancing comfort, enabling clinicians to better access difficult veins, and reducing overall procedure times.
BD BACTEC™ FX blood culture system
Advanced fluorescence detection technology, exceptional media performance and instrument reliability—adding vial-activated workflow, advanced ergonomics, blood culture observation and customer-focused data management.
BD BACTEC™ Blood Culture Media
Time to detection is important during the analytical phase. Learn about a full spectrum of blood culture media solutions.
BD Kiestra™ Lab Automation Solutions
BD Kiestra™ lab automation solutions support clinical microbiology labs with modular, scalable and open architecture solutions that can help increase efficiency, streamline processes and provide consistent results.
BD Synapsys™ Informatics Solution
Microbiology laboratories play a key role in infectious disease management. At the same time, they face a growing list of challenges, including lab consolidation, increased regulations, decreasing reimbursements and a shortage of skilled staff. That task is complicated by inherent obstacles such as manual processes, the lack of integrated workflows, disparate IT systems and difficulties accessing data.
Medication management solutions
The difference is one medication management partner and an integrated platform that unifies complex systems, practices and processes